vimarsana.com
Home
Live Updates
Advanced Accelerator Applications - Breaking News
Pages:
15
16
17
18
19
20
21
Page 14 - Advanced Accelerator Applications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Mirion Technologies Appoints Michael Rossi as President of Mirion Medical
Mirion Technologies Appoints Michael Rossi as President of Mirion Medical - read this article along with other careers information, tips and advice on BioSpace
United states
Philadelphia college of pharmacy
Michael rossi
Tom logan
Mirion technologies inc
Butler university
University of the sciences
Nuclear pharmacist certification
Syncor international
Ge healthcare
Radioligand imaging
Advanced accelerator applications
Jubilant pharma
Philadelphia college
Authorized nuclear pharmacist certification
Licensed pharmacist
Greater PSA Decline Predicts Better 177Lu-PSMA-617 Outcomes in mCRPC
PSA decline in men who receive 177Lu-PSMA-617 for mCRPC is associated with radiographic progression and death risk.
Advanced accelerator applications
177Lutetium-Octeotrate May Be Practice-Changing for Advanced Pancreatic Neuroendocrine Tumors
177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
France general
Eric baudin
Gustave roussy
Cancer campus
Advanced accelerator applications
Greater PSA Decline Predicts Better 177Lu-PSMA-617 Outcomes in mCRPC
PSA decline in men who receive 177Lu-PSMA-617 for mCRPC is associated with radiographic progression and death risk.
France general
North carolina
United states
Andrewj armstrong
Urologic cancers at duke university in durham
Novartis company
European society for medical oncology
Duke cancer institute center
European society
Medical oncology
Urologic cancers
Duke university
Advanced accelerator applications
177Lutetium-Octeotrate May Be Practice-Changing for Advanced Pancreatic Neuroendocrine Tumors
177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
France general
Eric baudin
Gustave roussy
Cancer campus
Advanced accelerator applications
vimarsana © 2020. All Rights Reserved.